Showing results (21-30 of 131) with videos related to

Sort By:
Pageof 14
International Journal of Molecular Sciences|March 15, 2019
Epigenetic Suppression of the T-box Subfamily 2 (<i>TBX2</i>) in Human Non-Small Cell Lung CancerEliana Nehme, Zahraa Rahal, Ansam Sinjab, et al.
Cancer Research|October 21, 2010
Gprc5a deletion enhances the transformed phenotype in normal and malignant lung epithelial cells by eliciting persistent Stat3 signaling induced by autocrine leukemia inhibitory factorYulong Chen, Jiong Deng, Junya Fujimoto, et al.
Plos One|October 2, 2020
Sex differences in gene expression with galactosylceramide treatment in Cln3Δex7/8 miceJoelle Makoukji, Sally El-Sitt, Nadine J Makhoul, et al.
Neoplasia (New York, N.Y.)|June 22, 2010
A Gprc5a tumor suppressor loss of expression signature is conserved, prevalent, and associated with survival in human lung adenocarcinomasHumam Kadara, Junya Fujimoto, Taoyan Men, et al.
Cell Systems|May 10, 2023
Deciphering tumor ecosystems at super resolution from spatial transcriptomics with TESLAJian Hu, Kyle Coleman, Daiwei Zhang, et al.
Molecules (Basel, Switzerland)|June 7, 2020
Anti-Tumor Effects of Biomimetic Sulfated Glycosaminoglycans on Lung Adenocarcinoma Cells in 2D and 3D In Vitro ModelsNada Al Matari, George Deeb, Hiba Mshiek, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
AP-1 mediated chromatin changes govern alveolar type 2 cell transition in lung injury-repairAnne M Lynch, Tala Noun, Sujuan Yang, et al.
Scientific Reports|September 8, 2015
LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cellsYuho Maki, Junya Fujimoto, Wenhua Lang, et al.
Frontiers in Oncology|April 20, 2019
Genome-Wide and Phenotypic Evaluation of Stem Cell Progenitors Derived From <i>Gprc5a</i>-Deficient Murine Lung Adenocarcinoma With Somatic <i>Kras</i> MutationsReem Daouk, Maya Hassane, Hisham F Bahmad, et al.
Plos One|August 14, 2020
Genome-wide gene expression analysis of a murine model of prostate cancer progression: Deciphering the roles of IL-6 and p38 MAPK as potential therapeutic targetsReem Daouk, Hisham F Bahmad, Eman Saleh, et al.
Pageof 14